J&J's Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Österreich Nachrichten Nachrichten

Österreich Neuesten Nachrichten,Österreich Schlagzeilen

Kenvue is parent to a host of household name brands, including Tylenol, Listerine, Band-Aid, Neutrogena and Nicorette

Johnson & Johnson’s consumer health company Kenvue is expected to hit the initial public offering market this week and mark the largest deal since late 2021.“With over $2 billion in cash flow and a healthy 3.7% dividend,... Johnson & Johnson’s consumer health company Kenvue is expected to hit the initial public offering market this week and mark the largest deal since late 2021.“With over $2 billion in cash flow and a healthy 3.

Kenvue is profitable, chalking up 1.46 billion in net income in the fiscal year through Jan. 1, on a pro forma basis, on sales that totaled $14.95 billion. In the first quarter through April 3, it had net income of 528 million on sales of $3.590 billion, according to the filing documents. J&J will cover all talc-related liabilities for products sold in the U.S. and Canada, while Kenvue will cover those sold overseas.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 3. in AT
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Österreich Neuesten Nachrichten, Österreich Schlagzeilen